Literature DB >> 10380115

Screening of lipase inhibitors from marine algae.

N Bitou1, M Ninomiya, T Tsujita, H Okuda.   

Abstract

The possible presence of an inhibitor of pancreatic lipase (triacylglycerol acylhydrolase, EC 3.1.1.3) was screened in 54 marine algae. An active inhibitor, caulerpenyne, was purified from an extract of Caulerpa taxifolia, using ethyl acetate extraction, followed by successive chromatographies on ODS and silica gel columns. The purified inhibitor was identified by thin-layer chromatography, infrared and nuclear magnetic resonance spectroscopy. Caulerpenyne competitively inhibited lipase activities using emulsified triolein and dispersed 4-methylumbelliferyl oleate (4-MU oleate) as substrates. The concentrations producing 50% inhibition against triolein and 4-MU oleate hydrolysis were 2 mM and 13 microM, respectively. In vivo, oral administration of corn oil with or without caulerpenyne to rats demonstrated a reduced and delayed peak plasma triacylglycerol concentration with caulerpenyne.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10380115     DOI: 10.1007/s11745-999-0383-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  16 in total

1.  Further studies of mode of action of lipolytic enzymes.

Authors:  J Rietsch; F Pattus; P Desnuelle; R Verger
Journal:  J Biol Chem       Date:  1977-06-25       Impact factor: 5.157

2.  Effects of tetrahydrolipstatin, a lipase inhibitor, on absorption of fat from the intestine of the rat.

Authors:  E Fernandez; B Borgström
Journal:  Biochim Biophys Acta       Date:  1989-02-20

3.  Overcoming problems of phenolics and quinones in the isolation of plant enzymes and organelles.

Authors:  W D Loomis
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

4.  On the function of bile salts and proteins as cofactors of lipase.

Authors:  H Brockerhoff
Journal:  J Biol Chem       Date:  1971-09-25       Impact factor: 5.157

5.  Inhibition of lipolysis by normal alcohols.

Authors:  F H Mattson; R A Volpenhein; L Benjamin
Journal:  J Biol Chem       Date:  1970-10-25       Impact factor: 5.157

6.  Effect of trypsin treatment of rat adipocytes on biological effects and binding of insulin and insulin-like growth factors: further evidence for the action of insulin-like growth factors through the insulin receptor.

Authors:  J Zapf; E Schoenle; M Waldvogel; I Sand; E R Froesch
Journal:  Eur J Biochem       Date:  1981-01

7.  Inhibition of lipolysis by hydrocarbons and fatty alcohols.

Authors:  G C Ferreira; J S Patton
Journal:  J Lipid Res       Date:  1990-05       Impact factor: 5.922

8.  Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity.

Authors:  E K Weibel; P Hadvary; E Hochuli; E Kupfer; H Lengsfeld
Journal:  J Antibiot (Tokyo)       Date:  1987-08       Impact factor: 2.649

9.  Cell growth inhibitory effects of caulerpenyne, a sesquiterpenoid from the marine algae Caulerpa taxifolia.

Authors:  J L Fischel; R Lemee; P Formento; C Caldani; J L Moll; D Pesando; A Meinesz; P Grelier; P Pietra; A Guerriero
Journal:  Anticancer Res       Date:  1995 Sep-Oct       Impact factor: 2.480

10.  Inhibition of pancreatic and microbial lipases by proteins.

Authors:  Y Gargouri; R Julien; A Sugihara; R Verger; L Sarda
Journal:  Biochim Biophys Acta       Date:  1984-09-12
View more
  13 in total

1.  The sesquiterpene caulerpenyne from Caulerpa spp. is a lipoxygenase inhibitor.

Authors:  Sevilay Cengiz; Levent Cavas; Kadir Yurdakoc; Georg Pohnert
Journal:  Mar Biotechnol (NY)       Date:  2010-06-22       Impact factor: 3.619

2.  Hypolipidemic effect of Salicornia herbacea in animal model of type 2 diabetes mellitus.

Authors:  Ji-Yeon Hwang; Soo-Kyung Lee; Ja-Rim Jo; Mi-Eun Kim; Hyun-Ah So; Chang-Woo Cho; Young-Wan Seo; Jung-In Kim
Journal:  Nutr Res Pract       Date:  2007-12-31       Impact factor: 1.926

3.  Beneficial effects of oolong tea consumption on diet-induced overweight and obese subjects.

Authors:  Rong-Rong He; Ling Chen; Bing-Hui Lin; Yokichi Matsui; Xin-Sheng Yao; Hiroshi Kurihara
Journal:  Chin J Integr Med       Date:  2009-03-07       Impact factor: 1.978

Review 4.  Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism.

Authors:  Yuguang Shi; Dong Cheng
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-30       Impact factor: 4.310

Review 5.  Bioactivities from marine algae of the genus Gracilaria.

Authors:  Cynthia Layse F de Almeida; Heloina de S Falcão; Gedson R de M Lima; Camila de A Montenegro; Narlize S Lira; Petrônio F de Athayde-Filho; Luis C Rodrigues; Maria de Fátima V de Souza; José M Barbosa-Filho; Leônia M Batista
Journal:  Int J Mol Sci       Date:  2011-07-15       Impact factor: 5.923

6.  Optimal Extraction Conditions of Anti-obesity Lipase Inhibitor from Phellinus linteus and Nutritional Characteristics of the Extracts.

Authors:  Jong-Kug Lee; Jung-Hwa Song; Jong-Soo Lee
Journal:  Mycobiology       Date:  2010-03-31       Impact factor: 1.858

7.  Extraction and Characteristics of Anti-obesity Lipase Inhibitor from Phellinus linteus.

Authors:  Jong-Kug Lee; Jeong-Hoon Jang; Jong-Tae Lee; Jong-Soo Lee
Journal:  Mycobiology       Date:  2010-03-31       Impact factor: 1.858

Review 8.  Inhibitors of pancreatic lipase: state of the art and clinical perspectives.

Authors:  Nitin A Lunagariya; Neeraj K Patel; Sneha C Jagtap; Kamlesh K Bhutani
Journal:  EXCLI J       Date:  2014-08-22       Impact factor: 4.068

Review 9.  Marine Algae as a Potential Source for Anti-Obesity Agents.

Authors:  Chu Wan-Loy; Phang Siew-Moi
Journal:  Mar Drugs       Date:  2016-12-07       Impact factor: 5.118

10.  Free radical scavenging, α-glucosidase inhibitory and lipase inhibitory activities of eighteen Sudanese medicinal plants.

Authors:  Sara Mustafa Idris Elbashir; Hari Prasad Devkota; Mikiyo Wada; Naoki Kishimoto; Masataka Moriuchi; Tsuyoshi Shuto; Shogo Misumi; Hirofumi Kai; Takashi Watanabe
Journal:  BMC Complement Altern Med       Date:  2018-10-19       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.